BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 12077578)

  • 1. The persistent risk of genital tumors among men treated with psoralen plus ultraviolet A (PUVA) for psoriasis.
    Stern RS; Bagheri S; Nichols K;
    J Am Acad Dermatol; 2002 Jul; 47(1):33-9. PubMed ID: 12077578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral psoralen and ultraviolet-A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA Follow-up Study.
    Stern RS; Liebman EJ; Väkevä L
    J Natl Cancer Inst; 1998 Sep; 90(17):1278-84. PubMed ID: 9731734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
    Stern RS
    Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
    Stern RS
    N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors associated with a second squamous cell carcinoma or basal cell carcinoma in psoralen + ultraviolet a light-treated psoriasis patients.
    Katz KA; Marcil I; Stern RS
    J Invest Dermatol; 2002 Jun; 118(6):1038-43. PubMed ID: 12060400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients.
    Lim JL; Stern RS
    J Invest Dermatol; 2005 Mar; 124(3):505-13. PubMed ID: 15737190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of ultraviolet mutations at the INK4a-ARF locus in squamous cell carcinomas from psoralen-plus-ultraviolet-A-treated psoriasis patients.
    Kreimer-Erlacher H; Seidl H; Bäck B; Cerroni L; Kerl H; Wolf P
    J Invest Dermatol; 2003 Apr; 120(4):676-82. PubMed ID: 12648234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PUVA and skin cancer. A historical cohort study on 492 patients.
    Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
    J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
    Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
    N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
    Stern RS;
    J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultraviolet exposure as the main initiator of p53 mutations in basal cell carcinomas from psoralen and ultraviolet A-treated patients with psoriasis.
    Seidl H; Kreimer-Erlacher H; Bäck B; Soyer HP; Höfler G; Kerl H; Wolf P
    J Invest Dermatol; 2001 Aug; 117(2):365-70. PubMed ID: 11511317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PUVA and cancer risk: the Swedish follow-up study.
    Lindelöf B; Sigurgeirsson B; Tegner E; Larkö O; Johannesson A; Berne B; Ljunggren B; Andersson T; Molin L; Nylander-Lundqvist E; Emtestam L
    Br J Dermatol; 1999 Jul; 141(1):108-12. PubMed ID: 10417523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genital squamous cell carcinoma in men treated by photochemotherapy. A cancer registry-based study from 1978 to 1998.
    Aubin F; Puzenat E; Arveux P; Louvat P; Quencez E; Humbert P
    Br J Dermatol; 2001 Jun; 144(6):1204-6. PubMed ID: 11422042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of skin cancer in the PUVA-48 cooperative study.
    Forman AB; Roenigk HH; Caro WA; Magid ML
    Arch Dermatol; 1989 Apr; 125(4):515-9. PubMed ID: 2649011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
    Stern RS; Nichols KT; Väkevä LH
    N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
    Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
    Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis.
    Stern RS; Lunder EJ
    Arch Dermatol; 1998 Dec; 134(12):1582-5. PubMed ID: 9875197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genital squamous-cell carcinoma after PUVA therapy.
    de la Brassinne M; Richert B
    Dermatology; 1992; 185(4):316-8. PubMed ID: 1477434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin tumors in the European PUVA Study. Eight-year follow-up of 1,643 patients treated with PUVA for psoriasis.
    Henseler T; Christophers E; Hönigsmann H; Wolff K
    J Am Acad Dermatol; 1987 Jan; 16(1 Pt 1):108-16. PubMed ID: 3805379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
    Nijsten TE; Stern RS
    J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.